Screening of Medicinal Plants for Development of Functional Food Ingredients with Anti-Obesity |
Kim, Yeong-Jin
(Department of Microbiology and Immunology, College of Medicine, Pusan National University)
Kim, Bo-Hye (Department of Microbiology and Immunology, College of Medicine, Pusan National University) Lee, Sun-Yi (Department of Microbiology and Immunology, College of Medicine, Pusan National University) Kim, Min-Soo (Korea Research Institute of Bioscience and Biotechnology) Park, Chan-Sun (Korea Research Institute of Bioscience and Biotechnology) Rhee, Moon-Soo (Korea Research Institute of Bioscience and Biotechnology) Lee, Kang-Hyun (Korea Research Institute of Bioscience and Biotechnology) Kim, Dong-Seob (School of Applied and Life Science, College of Natural Resources and Life Science, Pusan National University) |
1 | Diehl, A. K. (1991) Epidemiology and natural history of gallstone disease. Gastroenterol. Clin. N. Am. 20, 1-19 |
2 | Hadvay, P., Lengsfeld H. and Wolter H. (1988) Inhibition of pancreatic lipase in vitro by covalent inhibitor tetrahydrolipstatin. Biochem. J. 256, 357-361 DOI |
3 | Grundy, S. M. (1999) Hypertriglyceridemia, insulin resistance, and the metabolic syndrome. Am. J. Cardiol. 83, 25F-29F |
4 | Bray, G. A. and Popkin B. M. (1999) Dietary fat affects obesity rate. Am. J. Clin. Nutr. 70, 572-573 DOI |
5 | Rexrode, K. M., Manson J. E. and Hennekens C. H. (1996) Obesity and cardiovascular disease. Curr. Opin. Cardiol. 11, 490-495 DOI |
6 | Wada, K. and Ikeda.Y. (1998) Longitudinal studies to determine the effect of body fat rate reduction on blood pressure. J. Med. Syst. 22, 19-25 DOI ScienceOn |
7 | Alberti, K. G. and Zimmet P. Z. (1988) Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med. 13, 539-353 |
8 | Drent, M. L., Larsson I., William-Olsson T., Quaade F., Czubayko F., Von Bergmann K., Strobel W., Sjotro L. and Van der Veen E. A. (1995) Orlistat (RO 18-0647), a lipase inhibitor, in the treatment of human obesity: a multiple dose study. Int. J. Obes. 19, 221 -226 |
9 | Bitou, N., Nimomiya M., Tsjita T. and Okuda H. (1999) Screening of lipase inhibitors from marine algae. Lipids 34, 441-445 DOI ScienceOn |
10 | Freedman, D. S., Serdula M. K., Perey C. A. and Whitle L. (1997) Obesity levels of lipids and glucose, and smoking among Navajo adolescents. J. Nutr. 127, 2120S-2127S |
11 | Peter, C. and Williams G. (2001) Drug treatment of obesity: from past failures to future successes. Br. J. Clin. Pharmacol. 51, 135 |
12 | Larsson, B., Bjorntorp P. and Tibblin G. (1981) The health consequences of moderate obesity. Int. J. Obes. Relat. Metab. Disord. 5, 97-106 |
13 | Borgstom, B. (1986) Luminal digestion of fat. In The exocrine pancreas: biology, pathobiology, and disease. (1st ed.). pp. 361-373, Raven Press, New York |
14 | Bray, G. A. and Popkin B. M. (1998) Dietary fat intake dose affect obesity. Am. J. Clin. Nutr. 68, 1157-1173 DOI |
15 | Shimura, S., Tsuzuki W., Itho Y., Kobayashi S. and Suzuki T. (1994) Inhibitory effect of tannin fraction Cassia mimosoides L. var. nomame makino on lipase activity. Nippon Shokuhin Kogyo Gakkaishi. 41, 561-564 DOI ScienceOn |
16 | Zapf, J., Schoenole E. W., Waldvogel M., Sand M. and Froesch E. R. (1981) Effect of trypsin treatment of rat adipocyte on biological effects and binding of insulin and insulin-like growth factors: Further evidence for the action of insulin-like growth factors through the insulin receptor. Eur. J. Biochem. 133, 605-609 |
17 | Hauptman, J. B., Jeunet F. S. and Hartmann D. (1992) Initial studies in humans with the novel gastrointestinal lipase inhibitor Ro 18-0647 (tetrahydrolipstatin). Am. J. Clin. Nutr. 55, 309S -313S |
18 | Hadvary, P., Sidlerj W., Meister W., Vetter W. and Wolfer H. (1991) The lipase inhibitor tetrahydrolipstatin binds covalently to the putative active site serine of pancreatic lipase. J. Biol. Chem. 266, 2021-2027 |
19 | Yamamoto, M., Shimura S., Iyoh Y., Egawa M. and Ionue S. (2000) Anti-obesity effects of lipase inhibitor CT-II, an extract from edible herbs, Nomame Herba, on rats fed a high-fat diet. Int. J. Obesity 24, 758-764 DOI ScienceOn |
20 | World Health Organization Consultation on Obesity. (1998) Obesity: Preventing and Managing the Global Epidemic. World Health Organization: Geneva |
21 | Sjostrom, L., Rissanen A., Andersen T., Boldrin M., Golay A. and Koppeschaar H. P. F. (1998) Randomized placebocontrolled trial of orlistat for weight loss and prevention of weight regain in obese patients. Lancet 352, 167-172 DOI ScienceOn |
22 | Flegal, K. M., Carroll M. D., Ogden C. L. and Johnson C. L. (2002) Prevalence and trends in obesity among U.S. adults, 1999-2000. JAMA 288, 1723-1727 DOI |